Jeff Yass’s enGene Therapeutics Warrants ENGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.36K Buy
+16,801
New +$4.8K ﹤0.01% 13309

Other funds holding ENGNW

Jeff Yass's ENGNW Position: Q3 2026 in Review

Jeff Yass opened a new position in enGene Therapeutics Warrants (ENGNW) in Q3 2026: 16,801 shares worth $3.36K. The stake represents ﹤0.01% of the portfolio and ranks #13309 among its holdings.

12 funds tracked by Wall St. Rank hold ENGNW as of Q3 2026.

  • Jeff Yass held 16,801 shares of enGene Therapeutics Warrants worth $3.36K as of Q3 2026.
  • enGene Therapeutics Warrants was a new Jeff Yass position in Q3 2026.
  • enGene Therapeutics Warrants made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13309 holding.
  • 12 funds tracked by Wall St. Rank held enGene Therapeutics Warrants as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.